Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 6/20 | 0.53 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.50 |
| ▸ | CNR1 | P21554 | 9/20 | 0.49 |
| ▸ | CNR2 | P34972 | 9/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | APP | P05067 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1964193 | 0.93 | ESR1 (0.58) | ESR1ESR2CNR1CNR2ALDH1A1 | |
| SCHEMBL10821684 | 0.88 | ESR1 (0.53) | ESR1ESR2CNR1CNR2ALDH1A1 | |
| SCHEMBL28535695 | 0.84 | ESR1 (0.51) | ESR1ESR2CNR1CNR2ALDH1A1 | |
| SCHEMBL420915 | 0.82 | CNR1 (0.64) | ESR1CNR1CNR2 | |
| SCHEMBL1964125 | 0.79 | ESR1 (0.50) | ESR1ESR2CNR1CNR2ALDH1A1 | |
| SCHEMBL28971822 | 0.78 | ESR1 (0.63) | ESR1ESR2ALDH1A1HSD17B10 | |
| SCHEMBL11501040 | 0.77 | ESR1 (0.62) | ESR1ESR2ALDH1A1HSD17B10 | |
| SCHEMBL1966357 | 0.77 | ESR1 (0.62) | ESR1ESR2ALDH1A1HPGDALOX15 | |
| SCHEMBL27730143 | 0.76 | ESR1 (0.66) | ESR1ESR2ALDH1A1HSD17B10 | |
| SCHEMBL16769061 | 0.73 | ESR1 (0.56) | ESR1ESR2ALDH1A1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2334767-B1 | FATTY ESTER COMPOSITIONS WITH IMPROVED OXIDATIVE STABILITY | TAMINCO (BE) | 2013-05-29 | — | — | EP | disclosed |
| US-20110154724-A1 | FATTY ESTER COMPOSITIONS WITH IMPROVED OXIDATIVE STABILITY | TAMINCO (BE) | 2011-06-30 | — | — | US | disclosed |
| EP-2334767-A1 | FATTY ESTER COMPOSITIONS WITH IMPROVED OXIDATIVE STABILITY | Taminco (BE) | 2011-06-22 | — | — | EP | disclosed |
| WO-2010023277-A1 | FATTY ESTER COMPOSITIONS WITH IMPROVED OXIDATIVE STABILITY | TAMINCO (BE) | 2010-03-04 | — | — | WO | disclosed |
| US-7582126-B2 | Fatty ester compositions with improved oxidative stability | ARKEMA FRANCE (FR) | 2009-09-01 | — | — | US | disclosed |
| WO-2007078452-A2 | FATTY ESTER COMPOSITIONS WITH IMPROVED OXIDATIVE STABILITY | ARKEMA FRANCE (FR) | 2007-07-12 | — | — | WO | disclosed |
| US-20070137098-A1 | Fatty ester compositions with improved oxidative stability | ARKEMA FRANCE (FR) | 2007-06-21 | — | — | US | disclosed |
| US-4628132-A | DIALKYLAMINE, DIALKYLHYDROXYLAMINE, ALKALI METAL SALT OF TERT-ALKYL CATECHOL | ATLANTIC RICHFIELD COMPANY (US) | 1986-12-09 | — | — | US | disclosed |
| US-4511457-A | N,N*-PHENOTHIAZINE DIMER, TERT-ALKYL CATECHOL OR HYDROQUINONE | ATLANTIC RICHFIELD COMPANY (US) | 1985-04-16 | — | — | US | disclosed |
| US-4487981-A | ADDING N,N' DIMER OF PHENOTHIAZINE AND AN ALKYL CATECHOL OR ALKYL HYDROQUINONE | ATLANTIC RICHFIELD COMPANY (US) | 1984-12-11 | — | — | US | disclosed |
| US-4456526-A | USING A N,N-DIALKYLHYDROXLAMINE AND A TERTIARY-ALKYLCATECHOL | ATLANTIC RICHFIELD COMPANY (US) | 1984-06-26 | — | — | US | disclosed |
| US-4434307-A | N,N-DIARYLHYDROXYLAMINE, MONO-OR DI-TERT-BUTYL CATECHOL OR HYDROQUINONE | ATLANTIC RICHFIELD COMPANY (US) | 1984-02-28 | — | — | US | disclosed |
| US-4409408-A | DIALKYLHYDROXYLAMINES, TERT-ALKYL CATECHOLS | ATLANTIC RICHFIELD COMPANY (US) | 1983-10-11 | — | — | US | disclosed |